ASTELLAS PHARMA (Germany) Probability of Future Stock Price Finishing Over 14.63
| YPHA Stock | EUR 9.50 0.05 0.52% |
ASTELLAS |
ASTELLAS PHARMA Target Price Odds to finish over 14.63
The tendency of ASTELLAS Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 14.63 or more in 90 days |
| 9.50 | 90 days | 14.63 | close to zero percent |
Based on a normal probability distribution, the odds of ASTELLAS PHARMA to move over € 14.63 or more in 90 days from now is close to zero percent (This ASTELLAS PHARMA UNSPADR probability density function shows the probability of ASTELLAS Stock to fall within a particular range of prices over 90 days) . Probability of ASTELLAS PHARMA UNSPADR price to stay between its current price of € 9.50 and € 14.63 at the end of the 90-day period is about 91.37 .
Assuming the 90 days trading horizon ASTELLAS PHARMA has a beta of 0.33. This entails as returns on the market go up, ASTELLAS PHARMA average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ASTELLAS PHARMA UNSPADR will be expected to be much smaller as well. Additionally ASTELLAS PHARMA UNSPADR has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. ASTELLAS PHARMA Price Density |
| Price |
Predictive Modules for ASTELLAS PHARMA
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ASTELLAS PHARMA UNSPADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ASTELLAS PHARMA Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ASTELLAS PHARMA is not an exception. The market had few large corrections towards the ASTELLAS PHARMA's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ASTELLAS PHARMA UNSPADR, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ASTELLAS PHARMA within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.23 | |
β | Beta against Dow Jones | 0.33 | |
σ | Overall volatility | 0.44 | |
Ir | Information ratio | -0.18 |
ASTELLAS PHARMA Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ASTELLAS PHARMA for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ASTELLAS PHARMA UNSPADR can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ASTELLAS PHARMA generated a negative expected return over the last 90 days |
ASTELLAS PHARMA Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ASTELLAS Stock often depends not only on the future outlook of the current and potential ASTELLAS PHARMA's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ASTELLAS PHARMA's indicators that are reflective of the short sentiment are summarized in the table below.
| Dividend Yield | 0.0297 | |
| Forward Annual Dividend Rate | 0.39 | |
| Shares Float | 1.8 B |
ASTELLAS PHARMA Technical Analysis
ASTELLAS PHARMA's future price can be derived by breaking down and analyzing its technical indicators over time. ASTELLAS Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ASTELLAS PHARMA UNSPADR. In general, you should focus on analyzing ASTELLAS Stock price patterns and their correlations with different microeconomic environments and drivers.
ASTELLAS PHARMA Predictive Forecast Models
ASTELLAS PHARMA's time-series forecasting models is one of many ASTELLAS PHARMA's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ASTELLAS PHARMA's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about ASTELLAS PHARMA UNSPADR
Checking the ongoing alerts about ASTELLAS PHARMA for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ASTELLAS PHARMA UNSPADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ASTELLAS PHARMA generated a negative expected return over the last 90 days |
Other Information on Investing in ASTELLAS Stock
ASTELLAS PHARMA financial ratios help investors to determine whether ASTELLAS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ASTELLAS with respect to the benefits of owning ASTELLAS PHARMA security.